In addition, ATV did not modify the mRNA expression of IDO and IL-35 in MLN (Figures 3D–F), which are molecules capable of attenuating the inflammatory process in allergic asthma models (49–51); since we only evaluated the transcriptional expression of such factors, we do not rule out the possibility that these cytokines could be increased at the protein level. The gene discussed is IDO1; the disease is allergic asthma.